Related Experiment Video
Updated: Oct 14, 2025
07:54
Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
8.3K
Nanozymes in Tumor Theranostics.
Qiulian Ma1, Yanfang Liu2, Haitao Zhu1
1Department of Medical Imaging, The Affiliated Hospital of Jiangsu University, Zhenjiang, China.
Frontiers in Oncology
|November 5, 2021
Summary
Nanozymes, enzyme mimics, offer efficient catalysis under mild conditions, overcoming natural enzyme limitations. These advanced nanomaterials show significant promise in tumor diagnosis, therapy, and theranostics.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Catalysis
Background:
- Nanozymes are emerging enzyme mimics with high catalytic efficiency.
- They offer advantages over natural enzymes, including stability and cost-effectiveness.
- Their application in tumor biology is rapidly expanding.
Purpose of the Study:
- To review recent advancements in nanozyme applications for cancer research.
- To highlight nanozymes in tumor and tumor microenvironment diagnosis.
- To discuss nanozyme-based therapeutic and theranostic strategies.
Main Methods:
- Literature review of nanozyme research in oncology.
- Analysis of nanozyme mechanisms in biological systems.
- Synthesis of current trends in nanozyme-enabled cancer theranostics.
Main Results:
- Nanozymes demonstrate significant potential in tumor diagnosis and monitoring.
- They offer novel therapeutic strategies for cancer treatment.
- Integrated theranostic platforms based on nanozymes are advancing rapidly.
Conclusions:
- Nanozymes represent a promising frontier in oncology.
- Their unique properties facilitate innovative approaches to cancer diagnosis and therapy.
- Further development of nanozyme-based systems is crucial for clinical translation.
